nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—HRH3—digestive system—acquired immunodeficiency syndrome	0.00735	0.188	CbGeAlD
Betahistine—HRH3—blood—acquired immunodeficiency syndrome	0.007	0.179	CbGeAlD
Betahistine—HRH3—nervous system—acquired immunodeficiency syndrome	0.00568	0.146	CbGeAlD
Betahistine—HRH3—central nervous system—acquired immunodeficiency syndrome	0.00547	0.14	CbGeAlD
Betahistine—HRH3—brain—acquired immunodeficiency syndrome	0.00435	0.111	CbGeAlD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00319	0.0549	CbGpPWpGaD
Betahistine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00262	0.0029	CcSEcCtD
Betahistine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.0026	0.00288	CcSEcCtD
Betahistine—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.0026	0.00288	CcSEcCtD
Betahistine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00259	0.00287	CcSEcCtD
Betahistine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00259	0.00287	CcSEcCtD
Betahistine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.00258	0.00286	CcSEcCtD
Betahistine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00256	0.00284	CcSEcCtD
Betahistine—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.00256	0.00283	CcSEcCtD
Betahistine—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00255	0.00283	CcSEcCtD
Betahistine—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.00255	0.00282	CcSEcCtD
Betahistine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00255	0.00282	CcSEcCtD
Betahistine—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00254	0.00282	CcSEcCtD
Betahistine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00254	0.00281	CcSEcCtD
Betahistine—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00253	0.0028	CcSEcCtD
Betahistine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.00252	0.00279	CcSEcCtD
Betahistine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00251	0.00278	CcSEcCtD
Betahistine—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00251	0.00278	CcSEcCtD
Betahistine—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00251	0.00278	CcSEcCtD
Betahistine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.0025	0.00277	CcSEcCtD
Betahistine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.0025	0.00277	CcSEcCtD
Betahistine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00249	0.00275	CcSEcCtD
Betahistine—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.00275	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00247	0.00273	CcSEcCtD
Betahistine—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00245	0.00272	CcSEcCtD
Betahistine—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.00245	0.00271	CcSEcCtD
Betahistine—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00244	0.0027	CcSEcCtD
Betahistine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00243	0.0027	CcSEcCtD
Betahistine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00243	0.0027	CcSEcCtD
Betahistine—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.00243	0.00269	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00243	0.0418	CbGpPWpGaD
Betahistine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00242	0.00268	CcSEcCtD
Betahistine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00241	0.00267	CcSEcCtD
Betahistine—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.0024	0.00266	CcSEcCtD
Betahistine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.0024	0.00266	CcSEcCtD
Betahistine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00239	0.00265	CcSEcCtD
Betahistine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00239	0.00265	CcSEcCtD
Betahistine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00238	0.00264	CcSEcCtD
Betahistine—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00238	0.00263	CcSEcCtD
Betahistine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00237	0.00262	CcSEcCtD
Betahistine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00235	0.0026	CcSEcCtD
Betahistine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00235	0.0026	CcSEcCtD
Betahistine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00234	0.0026	CcSEcCtD
Betahistine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00234	0.00259	CcSEcCtD
Betahistine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00234	0.00259	CcSEcCtD
Betahistine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00233	0.00258	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00233	0.00258	CcSEcCtD
Betahistine—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00232	0.00257	CcSEcCtD
Betahistine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00232	0.00257	CcSEcCtD
Betahistine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00232	0.00257	CcSEcCtD
Betahistine—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.00231	0.00256	CcSEcCtD
Betahistine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00231	0.00256	CcSEcCtD
Betahistine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00231	0.00255	CcSEcCtD
Betahistine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00228	0.00253	CcSEcCtD
Betahistine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00228	0.00252	CcSEcCtD
Betahistine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00227	0.00251	CcSEcCtD
Betahistine—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00251	CcSEcCtD
Betahistine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00225	0.0025	CcSEcCtD
Betahistine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00225	0.00249	CcSEcCtD
Betahistine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00222	0.00246	CcSEcCtD
Betahistine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00221	0.00245	CcSEcCtD
Betahistine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00221	0.00245	CcSEcCtD
Betahistine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00221	0.00245	CcSEcCtD
Betahistine—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00221	0.00244	CcSEcCtD
Betahistine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00221	0.00244	CcSEcCtD
Betahistine—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.0022	0.00244	CcSEcCtD
Betahistine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.0022	0.00243	CcSEcCtD
Betahistine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00219	0.00242	CcSEcCtD
Betahistine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00219	0.00242	CcSEcCtD
Betahistine—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00218	0.00241	CcSEcCtD
Betahistine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00218	0.00241	CcSEcCtD
Betahistine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00217	0.0024	CcSEcCtD
Betahistine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00217	0.0024	CcSEcCtD
Betahistine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00216	0.00239	CcSEcCtD
Betahistine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00216	0.00239	CcSEcCtD
Betahistine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00214	0.00237	CcSEcCtD
Betahistine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00214	0.00237	CcSEcCtD
Betahistine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00214	0.00237	CcSEcCtD
Betahistine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00213	0.00235	CcSEcCtD
Betahistine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00212	0.00235	CcSEcCtD
Betahistine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00212	0.00235	CcSEcCtD
Betahistine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00212	0.00234	CcSEcCtD
Betahistine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00212	0.00234	CcSEcCtD
Betahistine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00211	0.00234	CcSEcCtD
Betahistine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00211	0.00234	CcSEcCtD
Betahistine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.00234	CcSEcCtD
Betahistine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.0021	0.00233	CcSEcCtD
Betahistine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.0021	0.00232	CcSEcCtD
Betahistine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00209	0.00232	CcSEcCtD
Betahistine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00209	0.00232	CcSEcCtD
Betahistine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00209	0.00231	CcSEcCtD
Betahistine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00208	0.00231	CcSEcCtD
Betahistine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00208	0.00231	CcSEcCtD
Betahistine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00208	0.0023	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00206	0.00228	CcSEcCtD
Betahistine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00206	0.00228	CcSEcCtD
Betahistine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00205	0.00227	CcSEcCtD
Betahistine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00205	0.00227	CcSEcCtD
Betahistine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00205	0.00227	CcSEcCtD
Betahistine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00227	CcSEcCtD
Betahistine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00203	0.00225	CcSEcCtD
Betahistine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00203	0.00225	CcSEcCtD
Betahistine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00202	0.00224	CcSEcCtD
Betahistine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00202	0.00224	CcSEcCtD
Betahistine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00202	0.00223	CcSEcCtD
Betahistine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00202	0.00223	CcSEcCtD
Betahistine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00201	0.00222	CcSEcCtD
Betahistine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00201	0.00222	CcSEcCtD
Betahistine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.002	0.00222	CcSEcCtD
Betahistine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00199	0.0022	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.0022	CcSEcCtD
Betahistine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00198	0.00219	CcSEcCtD
Betahistine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00197	0.00219	CcSEcCtD
Betahistine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00196	0.00217	CcSEcCtD
Betahistine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00195	0.00216	CcSEcCtD
Betahistine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00195	0.00216	CcSEcCtD
Betahistine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00195	0.00216	CcSEcCtD
Betahistine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00194	0.00215	CcSEcCtD
Betahistine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00194	0.00215	CcSEcCtD
Betahistine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00194	0.00215	CcSEcCtD
Betahistine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00194	0.00215	CcSEcCtD
Betahistine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00194	0.00215	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00193	0.0332	CbGpPWpGaD
Betahistine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00193	0.00214	CcSEcCtD
Betahistine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00193	0.00214	CcSEcCtD
Betahistine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00192	0.00213	CcSEcCtD
Betahistine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00192	0.00213	CcSEcCtD
Betahistine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00192	0.00213	CcSEcCtD
Betahistine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00192	0.00213	CcSEcCtD
Betahistine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00191	0.00212	CcSEcCtD
Betahistine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00191	0.00212	CcSEcCtD
Betahistine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00189	0.0021	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00189	0.0021	CcSEcCtD
Betahistine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00189	0.0021	CcSEcCtD
Betahistine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00188	0.00209	CcSEcCtD
Betahistine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00188	0.00208	CcSEcCtD
Betahistine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00188	0.00208	CcSEcCtD
Betahistine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00187	0.00207	CcSEcCtD
Betahistine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00186	0.00206	CcSEcCtD
Betahistine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00186	0.00206	CcSEcCtD
Betahistine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00186	0.00206	CcSEcCtD
Betahistine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00186	0.00206	CcSEcCtD
Betahistine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00186	0.00206	CcSEcCtD
Betahistine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00186	0.00206	CcSEcCtD
Betahistine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00186	0.00206	CcSEcCtD
Betahistine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00185	0.00205	CcSEcCtD
Betahistine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00185	0.00205	CcSEcCtD
Betahistine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00185	0.00204	CcSEcCtD
Betahistine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00185	0.00204	CcSEcCtD
Betahistine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00184	0.00204	CcSEcCtD
Betahistine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00184	0.00203	CcSEcCtD
Betahistine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00183	0.00203	CcSEcCtD
Betahistine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00183	0.00202	CcSEcCtD
Betahistine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00183	0.00202	CcSEcCtD
Betahistine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00182	0.00201	CcSEcCtD
Betahistine—HRH3—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.00182	0.0312	CbGpPWpGaD
Betahistine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00181	0.00201	CcSEcCtD
Betahistine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00201	CcSEcCtD
Betahistine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00179	0.00199	CcSEcCtD
Betahistine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00179	0.00198	CcSEcCtD
Betahistine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00178	0.00197	CcSEcCtD
Betahistine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00177	0.00197	CcSEcCtD
Betahistine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00177	0.00196	CcSEcCtD
Betahistine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00177	0.00196	CcSEcCtD
Betahistine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00176	0.00194	CcSEcCtD
Betahistine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00175	0.00194	CcSEcCtD
Betahistine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00175	0.00194	CcSEcCtD
Betahistine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00175	0.00194	CcSEcCtD
Betahistine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00175	0.00194	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00175	0.0301	CbGpPWpGaD
Betahistine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00172	0.00191	CcSEcCtD
Betahistine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.0019	CcSEcCtD
Betahistine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.0019	CcSEcCtD
Betahistine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00171	0.00189	CcSEcCtD
Betahistine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00171	0.00189	CcSEcCtD
Betahistine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00189	CcSEcCtD
Betahistine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.0017	0.00189	CcSEcCtD
Betahistine—HRH1—digestive system—acquired immunodeficiency syndrome	0.0017	0.0436	CbGeAlD
Betahistine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00169	0.00188	CcSEcCtD
Betahistine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00169	0.00187	CcSEcCtD
Betahistine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00168	0.00187	CcSEcCtD
Betahistine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00166	0.00184	CcSEcCtD
Betahistine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00165	0.00183	CcSEcCtD
Betahistine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00165	0.00183	CcSEcCtD
Betahistine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00182	CcSEcCtD
Betahistine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00163	0.0018	CcSEcCtD
Betahistine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00163	0.0018	CcSEcCtD
Betahistine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00163	0.0018	CcSEcCtD
Betahistine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00162	0.0018	CcSEcCtD
Betahistine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00179	CcSEcCtD
Betahistine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00161	0.00179	CcSEcCtD
Betahistine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00179	CcSEcCtD
Betahistine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00161	0.00178	CcSEcCtD
Betahistine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.0016	0.00178	CcSEcCtD
Betahistine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00159	0.00176	CcSEcCtD
Betahistine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00159	0.00176	CcSEcCtD
Betahistine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00158	0.00175	CcSEcCtD
Betahistine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00158	0.00175	CcSEcCtD
Betahistine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00175	CcSEcCtD
Betahistine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00175	CcSEcCtD
Betahistine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00157	0.00174	CcSEcCtD
Betahistine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00154	0.00171	CcSEcCtD
Betahistine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00171	CcSEcCtD
Betahistine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00152	0.00169	CcSEcCtD
Betahistine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00152	0.00169	CcSEcCtD
Betahistine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00152	0.00168	CcSEcCtD
Betahistine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00151	0.00168	CcSEcCtD
Betahistine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00167	CcSEcCtD
Betahistine—HRH1—vagina—acquired immunodeficiency syndrome	0.0015	0.0385	CbGeAlD
Betahistine—Rash—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00166	CcSEcCtD
Betahistine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00166	CcSEcCtD
Betahistine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00149	0.00165	CcSEcCtD
Betahistine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00149	0.00165	CcSEcCtD
Betahistine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00147	0.00163	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00147	0.0253	CbGpPWpGaD
Betahistine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00147	0.00162	CcSEcCtD
Betahistine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00145	0.00161	CcSEcCtD
Betahistine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.00158	CcSEcCtD
Betahistine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00143	0.00158	CcSEcCtD
Betahistine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.00158	CcSEcCtD
Betahistine—HRH1—lung—acquired immunodeficiency syndrome	0.00142	0.0364	CbGeAlD
Betahistine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00157	CcSEcCtD
Betahistine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00142	0.00157	CcSEcCtD
Betahistine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00141	0.00157	CcSEcCtD
Betahistine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.00156	CcSEcCtD
Betahistine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00141	0.00156	CcSEcCtD
Betahistine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00156	CcSEcCtD
Betahistine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.00152	CcSEcCtD
Betahistine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.00152	CcSEcCtD
Betahistine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.00151	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00136	0.0234	CbGpPWpGaD
Betahistine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.0015	CcSEcCtD
Betahistine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.0015	CcSEcCtD
Betahistine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.0015	CcSEcCtD
Betahistine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00135	0.00149	CcSEcCtD
Betahistine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00135	0.00149	CcSEcCtD
Betahistine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00134	0.00148	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00133	0.0229	CbGpPWpGaD
Betahistine—HRH1—nervous system—acquired immunodeficiency syndrome	0.00132	0.0337	CbGeAlD
Betahistine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00132	0.00146	CcSEcCtD
Betahistine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00131	0.00145	CcSEcCtD
Betahistine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00145	CcSEcCtD
Betahistine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00143	CcSEcCtD
Betahistine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00128	0.00142	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00128	0.022	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00128	0.022	CbGpPWpGaD
Betahistine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00127	0.0325	CbGeAlD
Betahistine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.0014	CcSEcCtD
Betahistine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.0014	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00126	0.0217	CbGpPWpGaD
Betahistine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00139	CcSEcCtD
Betahistine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00139	CcSEcCtD
Betahistine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00139	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00125	0.0214	CbGpPWpGaD
Betahistine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00138	CcSEcCtD
Betahistine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.00135	CcSEcCtD
Betahistine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00121	0.00134	CcSEcCtD
Betahistine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00134	CcSEcCtD
Betahistine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00134	CcSEcCtD
Betahistine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.0012	0.00133	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00119	0.0205	CbGpPWpGaD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00119	0.0204	CbGpPWpGaD
Betahistine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00131	CcSEcCtD
Betahistine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00129	CcSEcCtD
Betahistine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00128	CcSEcCtD
Betahistine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00128	CcSEcCtD
Betahistine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00127	CcSEcCtD
Betahistine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00126	CcSEcCtD
Betahistine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.0012	CcSEcCtD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00108	0.0186	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00105	0.0181	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00102	0.0175	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00102	0.0175	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.00101	0.0173	CbGpPWpGaD
Betahistine—HRH1—brain—acquired immunodeficiency syndrome	0.00101	0.0258	CbGeAlD
Betahistine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000972	0.0249	CbGeAlD
Betahistine—HRH3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000972	0.0167	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00091	0.0156	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000876	0.0151	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000823	0.0141	CbGpPWpGaD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000813	0.014	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000803	0.0138	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000774	0.0133	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000774	0.0133	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000773	0.0133	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000756	0.013	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000737	0.0127	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000696	0.012	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000684	0.0117	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000639	0.011	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000589	0.0101	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000578	0.00993	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00053	0.00911	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000487	0.00836	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000467	0.00802	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000465	0.00799	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000446	0.00767	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000446	0.00767	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00044	0.00756	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000437	0.00751	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000437	0.00751	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000422	0.00726	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000417	0.00716	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000412	0.00708	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000404	0.00694	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000397	0.00682	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000397	0.00682	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000395	0.00678	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000392	0.00673	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000357	0.00613	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000336	0.00577	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000336	0.00577	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000333	0.00572	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000328	0.00563	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000302	0.00519	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000301	0.00517	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.0003	0.00515	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000298	0.00511	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000276	0.00474	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000272	0.00468	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000272	0.00467	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000268	0.00461	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000256	0.00439	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000256	0.00439	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000255	0.00439	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00025	0.00429	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000249	0.00429	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000243	0.00418	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000235	0.00403	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000235	0.00403	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00023	0.00395	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000226	0.00388	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000194	0.00334	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000178	0.00307	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000176	0.00302	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000175	0.00301	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000173	0.00298	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000161	0.00276	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000157	0.0027	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000154	0.00265	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000154	0.00264	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000147	0.00253	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000147	0.00253	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000144	0.00248	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000144	0.00248	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000139	0.0024	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000133	0.00229	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000131	0.00225	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000131	0.00225	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00011	0.00189	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000108	0.00186	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000105	0.00181	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.98e-05	0.00171	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.9e-05	0.0017	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.83e-05	0.00169	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.29e-05	0.0016	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.24e-05	0.00159	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.11e-05	0.00157	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.99e-05	0.00154	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.24e-05	0.00142	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.75e-05	0.00133	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.75e-05	0.00133	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.89e-05	0.00101	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.81e-05	0.000998	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.72e-05	0.000983	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.46e-05	0.000938	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.31e-05	0.000913	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.19e-05	0.000893	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.07e-05	0.000527	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.05e-05	0.000525	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.8e-05	0.00031	CbGpPWpGaD
